Ensysce Biosciences, Inc. Common Stock
Veridion Score
BETALOW CONF · 4/6 factorsComposite intelligence score across six company factor categories. Missing inputs are excluded from the active factor subset.
- · Factor breakdown with raw signals
- · Day-over-day delta + driver
- · Factor coverage readout
- · Valuation · hype · market flow
- · Pro Chart event markers
- · Score history + alerts
Why is ENSC moving today?
Ensysce Biosciences Inc is a clinical-stage biotech company using its proprietary technology platforms to develop safer prescription drugs. The company is developing a new class of powerful, opioids that prevent both drug abuse and overdoses. Its products are anticipated to provide safer options to treat severe pain and assist in preventing deaths caused by opioid abuse, reducing human and economic costs. The company's current development pipeline includes two new drug platforms: an abuse-resistant opioid prodrug technology, theTrypsin Activated Abuse Protection, or the TAAP platform, and an over-dose protection opioid prodrug technology, the Multi-Pill Abuse Resistant, or the MPAR platform. The Company currently operates in one business segment, which is pharmaceuticals.
Reported fields plus Veridion-computed history. Unsourced tiles are omitted.
ENSC overview
Related filings and maps
Congress activity in ENSC
No receipt-qualified Congressional disclosure is present for ENSC in the cached public ledger.
ENSC contract awards, year to date.
Public federal awards linked to this ticker.
ENSC lobbying filings, year to date.
Registered lobbying filings matched to Ensysce Biosciences, Inc. Common Stock.